ARS Pharmaceuticals Inc (SPRY)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Laura K. Shawver
Employees:
90
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO, CA, 92130
858-771-9307

Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.

Data derived from most recent annual or quarterly report
Market Cap 264.956 Million Shares Outstanding35.14 Million Avg 30-day Volume 144.727 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.7
Price to Revenue0.0 Debt to Equity0.0 EBITDA-86.222 Million
Price to Book Value0.7013 Operating Margin0.0 Enterprise Value-79.322 Million
Current Ratio67.869 EPS Growth-1.149 Quick Ratio66.823
1 Yr BETA 1.0173 52-week High/Low 7.79 / 2.8 Profit Margin0.0
Operating Cash Flow Growth-28.698 Altman Z-Score27.0068 Free Cash Flow to Firm -69.773 Million
View SEC Filings from SPRY instead.

View recent insider trading info

Funds Holding SPRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SPRY

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-12-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 8.01: Other Events
  • 8-K: filed on 2022-10-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-21:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    8.3 Thousand total shares from 1 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FITZPATRICK ALEXANDER A CHIEF LEGAL OFFICER

    • Officer
    0 2022-12-01 1

    SCOTT KATHLEEN D. CHIEF FINANCIAL OFFICER

    • Officer
    8,250 2022-11-29 3

    FLYNN JAMES E

    DEERFIELD MGMT III, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD MGMT IV, L.P.

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
    11,077,928 2022-11-08 1

    LEFF JONATHAN S

    • Director
    0 2022-11-08 1

    SCHNEIDER PHILLIP M

    • Director
    0 2022-11-08 2

    SAUNDERS BRENT L

    • Director
    0 2022-11-08 2

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND II, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    0 2022-11-08 2

    LOWENTHAL RICHARD E PRESIDENT AND CEO

    • Officer
    • Director
    • 10% Owner
    0 2022-11-08 2

    SHAH PRATIK

    PRATIK SHAH LIVING TRUST DATED JUNE 15, 2011

    • Director
    • 10% Owner
    0 2022-11-08 2

    CHAKMA JUSTIN CHIEF BUSINESS OFFICER

    • Officer
    0 2022-11-08 2

    KARAS ERIC CHIEF COMMERCIAL OFFICER

    • Officer
    0 2022-11-08 2

    TANIMOTO SARINA CHIEF MEDICAL OFFICER

    • Officer
    • 10% Owner
    0 2022-11-08 2

    DADOO RAJEEV

    • Director
    0 2022-11-08 2

    KELLY MICHAEL

    • Director
    0 2022-11-08 2

    PEPE JEFFREY C. INTERIM CEO AND GC

    • Officer
    52,323 2022-09-02 1

    SHAWVER LAURA CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    657,239 2022-08-05 1

    ROOT JONATHAN D

    • Director
    18,000 2022-06-10 1

    CAPPS VICKIE L

    • Director
    18,000 2022-06-10 1

    HERSHBERG ROBERT

    • Director
    18,000 2022-06-10 1

    POWELL ANDREW KENNETH WILLIAM

    • Director
    18,000 2022-06-10 1

    THOMPSON PETER A.

    • Director
    • 10% Owner
    18,000 2022-06-10 1

    ISLAM SAQIB

    • Director
    18,000 2022-06-10 1

    KOEHLER MARIA

    • Director
    18,000 2022-06-10 1

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SCOTT KATHLEEN D. - Officer CHIEF FINANCIAL OFFICER see footnote

    2022-12-01 16:31:51 -0500 2022-11-29 P 8,250 $6.24 a 8,250 indirect 3.1519 3.1519 2 0.0 1

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER by sarina tanimoto charitable remainder unitrust dated january 7, 2020

    2022-11-10 18:00:35 -0500 2022-11-08 A 1,772,850 a 1,772,850 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER by spouse

    2022-11-10 18:00:35 -0500 2022-11-08 A 236,380 a 236,380 indirect

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER by richard lowenthal charitable remainder unitrust dated january 7, 2020

    2022-11-10 18:00:35 -0500 2022-11-08 A 1,772,850 a 1,772,850 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER

    2022-11-10 18:00:35 -0500 2022-11-08 A 4,326,854 a 4,326,854 direct -1.9481 -3.5714 5.5195 3 -3.5714 6

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER by spouse

    2022-11-10 18:00:35 -0500 2022-11-08 A 4,326,854 a 4,326,854 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    RA CAPITAL MANAGEMENT, L.P. - Director see footnotes

    RA CAPITAL HEALTHCARE FUND LP - Director see footnotes

    RA CAPITAL NEXUS FUND II, L.P. - Director see footnotes

    KOLCHINSKY PETER - Director see footnotes

    SHAH RAJEEV M. - Director see footnotes

    2022-11-10 18:00:43 -0500 2022-11-08 A 902,904 a 902,904 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    RA CAPITAL MANAGEMENT, L.P. - Director see footnotes

    RA CAPITAL HEALTHCARE FUND LP - Director see footnotes

    RA CAPITAL NEXUS FUND II, L.P. - Director see footnotes

    KOLCHINSKY PETER - Director see footnotes

    SHAH RAJEEV M. - Director see footnotes

    2022-11-10 18:00:43 -0500 2022-11-08 A 2,106,774 a 2,106,774 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    SCHNEIDER PHILLIP M - Director

    2022-11-10 18:00:44 -0500 2022-11-08 A 76,823 a 76,823 direct

    SCHNEIDER PHILLIP M - Director

    2022-11-10 18:00:44 -0500 2022-11-08 A 153,647 a 153,647 direct

    KARAS ERIC - Officer CHIEF COMMERCIAL OFFICER

    2022-11-10 18:00:47 -0500 2022-11-08 A 614,588 a 614,588 direct

    SHAH PRATIK - Director - > 10% Owner

    PRATIK SHAH LIVING TRUST DATED JUNE 15, 2011 - > 10% Owner

    2022-11-10 18:00:49 -0500 2022-11-08 A 354,570 a 354,570 direct

    SHAH PRATIK - Director - > 10% Owner by the pratik shah living trust dated june 15, 2011

    PRATIK SHAH LIVING TRUST DATED JUNE 15, 2011 - > 10% Owner by the pratik shah living trust dated june 15, 2011

    2022-11-10 18:00:49 -0500 2022-11-08 A 10,156,204 a 10,156,204 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    CHAKMA JUSTIN - Officer CHIEF BUSINESS OFFICER

    2022-11-10 18:00:54 -0500 2022-11-08 A 48,260 a 48,260 direct

    CHAKMA JUSTIN - Officer CHIEF BUSINESS OFFICER

    2022-11-10 18:00:54 -0500 2022-11-08 A 82,733 a 82,733 direct

    CHAKMA JUSTIN - Officer CHIEF BUSINESS OFFICER

    2022-11-10 18:00:54 -0500 2022-11-08 A 236,380 a 236,380 direct -1.9481 -3.5714 5.5195 3 -3.5714 6

    CHAKMA JUSTIN - Officer CHIEF BUSINESS OFFICER

    2022-11-10 18:00:54 -0500 2022-11-08 A 236,380 a 236,380 direct

    CHAKMA JUSTIN - Officer CHIEF BUSINESS OFFICER

    2022-11-10 18:00:54 -0500 2022-11-08 A 236,380 a 236,380 direct

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO

    2022-11-10 18:00:28 -0500 2022-11-08 A 236,380 a 236,380 direct

    DADOO RAJEEV - Director see note 2

    2022-11-10 18:00:15 -0500 2022-11-08 A 3,009,677 a 3,009,677 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    KELLY MICHAEL - Director

    2022-11-10 18:00:20 -0500 2022-11-08 A 70,422 a 70,422 direct

    KELLY MICHAEL - Director the 2019 michael kelly irrevocable deed of trust

    2022-11-10 18:00:20 -0500 2022-11-08 A 83,225 a 83,225 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    KELLY MICHAEL - Director

    2022-11-10 18:00:20 -0500 2022-11-08 A 118,190 a 118,190 direct

    SAUNDERS BRENT L - Director

    2022-11-10 18:00:24 -0500 2022-11-08 A 153,647 a 153,647 direct

    SAUNDERS BRENT L - Director

    2022-11-10 18:00:24 -0500 2022-11-08 A 590,950 a 590,950 direct

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO by spouse

    2022-11-10 18:00:28 -0500 2022-11-08 A 82,733 a 82,733 indirect

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO by spouse

    2022-11-10 18:00:28 -0500 2022-11-08 A 82,733 a 82,733 indirect

    SCOTT KATHLEEN D. - Officer CHIEF FINANCIAL OFFICER

    2022-11-10 18:00:12 -0500 2022-11-08 A 827,330 a 827,330 direct

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO

    2022-11-10 18:00:28 -0500 2022-11-08 A 236,380 a 236,380 direct

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO by richard e. lowenthal charitable remainder unitrust dated january 7, 2020

    2022-11-10 18:00:28 -0500 2022-11-08 A 1,772,850 a 1,772,850 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO by sarina tanimoto charitable remainder unitrust dated january 7, 2020

    2022-11-10 18:00:28 -0500 2022-11-08 A 1,772,850 a 1,772,850 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO by spouse

    2022-11-10 18:00:28 -0500 2022-11-08 A 4,326,854 a 4,326,854 indirect -1.9481 -3.5714 5.5195 3 -3.5714 6

    LOWENTHAL RICHARD E - Director - Officer - > 10% Owner PRESIDENT AND CEO

    2022-11-10 18:00:28 -0500 2022-11-08 A 5,176,822 a 5,176,822 direct -1.9481 -3.5714 5.5195 3 -3.5714 6

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER

    2022-11-10 18:00:35 -0500 2022-11-08 A 82,733 a 82,733 direct

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER

    2022-11-10 18:00:35 -0500 2022-11-08 A 82,733 a 82,733 direct

    TANIMOTO SARINA - Officer - > 10% Owner CHIEF MEDICAL OFFICER by spouse

    2022-11-10 18:00:35 -0500 2022-11-08 A 236,380 a 236,380 indirect

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 18:45:03 UTC 1.5882 2.2318 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 18:15:03 UTC 1.5882 2.2318 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 17:45:03 UTC 1.5882 2.2318 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 17:15:03 UTC 1.5882 2.2318 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 16:45:03 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 16:15:03 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 15:45:03 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 15:15:03 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 14:45:04 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 14:15:03 UTC 1.5942 2.2258 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 13:45:03 UTC 1.3149 2.5051 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 13:15:03 UTC 1.3149 2.5051 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-09 12:45:03 UTC 1.3149 2.5051 1200000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 22:15:03 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 21:45:04 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 21:15:03 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 20:45:04 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 20:15:05 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 19:45:04 UTC 1.3149 2.5051 2000000
    ARS PHARMACEUTICALS INC SPRY 2022-12-08 19:15:03 UTC 1.3149 2.5051 2000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments